Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.


Latest Press Releases

Rural Health Transformation Reality Check: What Rural Hospital Decision-Makers Will Fund in 2026 and What They Won't
Healthcare & PharmaceuticalProduct Announcements

Rural Health Transformation Reality Check: What Rural Hospital Decision-Makers Will Fund in 2026 and What They Won't

February 2, 2026 9:50 AM

Ahead of the AHA Rural Health Care Leadership Conference (Feb. 8-11, San Antonio), Black Book Market Research today released findings from its Q1 2026 Rural Transformation Readiness Survey of rural, small, and critical access hospitals (CAHs). The results show a decisive shift from feature-first purchasing to delivery certainty: execution capacity, auditable outcomes, cybersecurity resilience, integration scope clarity, interoperability...

Read more
NanoViricides President Dr. Diwan Interviewed by Mission Matters' Adam Torres
Healthcare & PharmaceuticalConferences

NanoViricides President Dr. Diwan Interviewed by Mission Matters' Adam Torres

February 2, 2026 8:30 AM

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced today that our President Dr. Anil R. Diwan was interviewed on the Mission Matters Podcast by Mr. Adam Torres. The interview video is available at https://youtu.be/nU_2dgd-u1g. Mr. Torres began with asking what is the mission of NanoViricides. Dr. Diwan responded that...

Read more
AlzeCure Pharma Selected to Present at the Bio-Neuroscience conference in Amsterdam
Healthcare & PharmaceuticalCompany Update

AlzeCure Pharma Selected to Present at the Bio-Neuroscience conference in Amsterdam

February 2, 2026 7:15 AM

AlzeCure Pharma AB (publ) (FN STO:ALZCUR)(FRA:AC6), a biotech company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that the company has been selected to present at Bio‑Neuroscience 2026, an international partnering and investor conference in neuroscience, taking place in Amsterdam, the Netherlands, on February 24-26, 2026. Bio-Neuroscience is a world-leading...

Read more
NHI Announces $105.5 Million SHOP Investment
Healthcare & PharmaceuticalMergers and Acquisitions

NHI Announces $105.5 Million SHOP Investment

February 2, 2026 6:00 AM

National Health Investors, Inc. (NYSE:NHI) announced today that it invested $105.5 million, including transaction costs, for the acquisition of nine properties with 460 units in Kentucky, South Carolina and Tennessee. NHI expects to make an additional investment of $3.3 million during the first year. The properties and healthcare operations will be included in NHI's Senior Housing Operating Portfolio ("SHOP") segment and will be managed by...

Read more
Umbrella Labs Cagrilintide Peptide Research Use Only Program Expands Laboratory Access For High Rigor Amylin Receptor, Calcitonin Receptor, And Neuroendocrine Signaling Bench Science
Healthcare & PharmaceuticalCompany Update

Umbrella Labs Cagrilintide Peptide Research Use Only Program Expands Laboratory Access For High Rigor Amylin Receptor, Calcitonin Receptor, And Neuroendocrine Signaling Bench Science

February 2, 2026 5:20 AM

Umbrella Labs today announced an expanded research procurement program for cagrilintide peptide to support laboratories running amylin receptor complex profiling, calcitonin receptor signaling studies, and neuroendocrine pathway mapping in controlled bench environments. The program is built for repeatability and documentation discipline, with stable catalog references, batch traceability, and specification forward listings intended to support...

Read more
AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research
Healthcare & PharmaceuticalCompany Update

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

January 31, 2026 8:00 AM

Black Book Research today announced the publication of its position statement, "Market Research Integrity and Insight in the AI Era," establishing a comprehensive framework to safeguard survey, polling, and satisfaction-based research against emerging risks accelerated by generative AI while using AI responsibly to improve research operations without compromising the truth source of benchmark findings. Generative AI is simultaneously increasing...

Read more
Janice Crowder, MD, Calls for Action to Reduce Maternal Mortality
Healthcare & PharmaceuticalCompany Update

Janice Crowder, MD, Calls for Action to Reduce Maternal Mortality

January 30, 2026 4:30 PM

Janice Crowder, MD, a board-certified obstetrician-gynecologist with more than 3 decades of experience, is speaking out to raise awareness of maternal mortality and the practical steps individuals can take to reduce risk before, during, and after pregnancy. Maternal mortality remains a serious public health issue in the United States. The U.S. continues to have one of the highest maternal mortality rates among developed countries. Black women,...

Read more
TRNR Publishes Comprehensive Sportstech Documentation for Shareholders
Healthcare & PharmaceuticalCompany Update

TRNR Publishes Comprehensive Sportstech Documentation for Shareholders

January 30, 2026 2:25 PM

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the Wattbike, CLMBR, and FORME brands, today published a comprehensive summary of the Sportstech transaction, including source materials and SEC filings, on its website. Trent Ward, Founder and CEO, stated: "We are not sure why Sportstech feels the need to issue press releases targeted towards public-market investors, given...

Read more
Science And Medicine Group Announces Two New Radiology Podcast Series On AuntMinnie.com
Healthcare & PharmaceuticalAdvertorial

Science And Medicine Group Announces Two New Radiology Podcast Series On AuntMinnie.com

January 30, 2026 10:30 AM

Science and Medicine Group (SMG) and AuntMinnie.com have launched two new series of podcasts focused on women's imaging and ultrasound topics. Available today, the inaugural episode (link here) for the Women's Imaging MinnieCast series features a wide-ranging video interview with Amy Patel, MD, on "radvocacy" and how radiologists can make a difference. In addition, the first episode in the Ultrasound MinnieCast series includes a conversation...

Read more
Understanding When to Use Fillers or Neurotoxins According to Dr. Ran Rubinstein
Healthcare & PharmaceuticalCompany Update

Understanding When to Use Fillers or Neurotoxins According to Dr. Ran Rubinstein

January 30, 2026 9:00 AM

Injectable aesthetic treatments continue to grow in popularity, yet confusion remains around when dermal fillers are appropriate versus when neurotoxins are the better option. Facial plastic surgeon and national injectables trainer Dr. Ran Rubinstein emphasizes that understanding how these treatments differ is essential to achieving natural, balanced results. As a board-certified facial plastic surgeon certified by the American Board of Facial...

Read more
Genflow Biosciences PLC Announces Holding(s) in Company
Healthcare & PharmaceuticalRegulatory

Genflow Biosciences PLC Announces Holding(s) in Company

January 30, 2026 8:25 AM

TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BP2C3V08 Issuer Name GENFLOW BIOSCIENCES PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting rights 3. Details of person subject to the notification obligation Name Jonathan Mark Swann City of registered office (if applicable) rickmansworth Country of registered office (if applicable) United Kingdom 4. Details of the...

Read more
Dr. David Berman to Join Moderna as Chief Development Officer
Healthcare & PharmaceuticalCompany Update

Dr. David Berman to Join Moderna as Chief Development Officer

January 30, 2026 7:30 AM

Moderna, Inc. (NASDAQ:MRNA) today announced that David Berman, M.D., Ph.D. has been appointed as the Company's Chief Development Officer, beginning March 2, 2026. He will serve on Moderna's Executive Committee and report to Chief Executive Officer Stéphane Bancel. Dr. Jacqueline Miller will step down as Chief Medical Officer and member of the Executive Committee effective the same date and will remain as a consultant to the Company to assist...

Read more
Esteworld Turkey Highlights Expertise of Medical Director Dr. Burak Tuncer
Healthcare & PharmaceuticalCompany Update

Esteworld Turkey Highlights Expertise of Medical Director Dr. Burak Tuncer

January 30, 2026 7:20 AM

Esteworld Turkey has continued to expand structured medical services across aesthetic and reconstructive procedures under the clinical leadership of Medical Director Dr. Burak Tuncer. With a background in plastic, reconstructive, and aesthetic surgery, Dr. Burak Tuncer oversees treatment protocols, surgical standards, and multidisciplinary coordination at Esteworld Turkey, with a particular focus on procedures involving the Breast, including...

Read more
How to Choose the Right Pharmacy Services Partner: Key Criteria for Hospitals & Health Systems
Healthcare & PharmaceuticalCompany Update

How to Choose the Right Pharmacy Services Partner: Key Criteria for Hospitals & Health Systems

January 29, 2026 5:15 PM

In an era where staffing shortages, cost containment, and regulatory complexity challenge healthcare operations, pharmacy support offers hospitals and health systems a strategic advantage. But selecting the right partner is more than a logistical decision - it's a critical investment in patient safety, operational efficiency, and compliance. For rural hospitals, community health centers, specialty clinics, and integrated health systems, the...

Read more
Moderna Announces Strategic Collaboration with Recordati to Globally Commercialize Investigational Propionic Acidemia Therapeutic (mRNA-3927)
Healthcare & PharmaceuticalPartnerships

Moderna Announces Strategic Collaboration with Recordati to Globally Commercialize Investigational Propionic Acidemia Therapeutic (mRNA-3927)

January 29, 2026 5:00 PM

Moderna, Inc. (NASDAQ:MRNA) today announced a strategic collaboration with Recordati to advance Moderna's investigational propionic acidemia (PA) therapeutic, mRNA-3927, through the final stages of clinical development and, upon approval, global commercialization. Recordati, based in Milan, Italy, is an international pharmaceutical group that provides treatments across specialty and primary care, and rare diseases, including PA. Through this...

Read more
Pharma-Bio Serv Announces Full Year Results and Special Dividend
Healthcare & PharmaceuticalDividends

Pharma-Bio Serv Announces Full Year Results and Special Dividend

January 29, 2026 5:00 PM

Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a regulatory affairs, quality, compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, medical device, cosmetic, food and allied products industries, today announced that revenues for the year ended October 31, 2025 were approximately $9.0 million, a decrease of approximately $0.5 million...

Read more
Pro-Dex, Inc. Announces Fiscal 2026 Second Quarter and Six-Month Results
Healthcare & PharmaceuticalEarnings

Pro-Dex, Inc. Announces Fiscal 2026 Second Quarter and Six-Month Results

January 29, 2026 4:00 PM

PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2026 second quarter ended December 31, 2025. The Company also filed its Quarterly Report on Form 10-Q for the second quarter of fiscal year 2026 with the Securities and Exchange Commission today. Quarter Ended December 31, 2025 Net sales for the three months ended December 31, 2025, increased $1.9 million, or 11%, to $18.7 million from $16.8 million for the three...

Read more
Medical Component Specialists to Exhibit at MD&M West 2026 - Booth #3277
Healthcare & PharmaceuticalConferences

Medical Component Specialists to Exhibit at MD&M West 2026 - Booth #3277

January 29, 2026 1:25 PM

Medical Component Specialists (MCS) will be exhibited at booth #3277, during MD&M West 2026, taking place February 3-5 at the Anaheim Convention Center in Anaheim, California. The event brings together leaders, suppliers, and innovators from across the advanced manufacturing industry and is recognized as one of the most comprehensive manufacturing trade shows in North America. MD&M West unites five interconnected sectors, MedTech, Automation,...

Read more
LIV Recovery Center Expands Focus on Dual Diagnosis Treatment
Healthcare & PharmaceuticalCompany Update

LIV Recovery Center Expands Focus on Dual Diagnosis Treatment

January 29, 2026 11:00 AM

LIV Recovery Center, a behavioral and mental health treatment clinic located in Alpharetta, Georgia, is advancing its dual diagnosis treatment services to better serve the needs of individuals with co-occurring mental health and substance use disorders. The effort is part of a larger shift toward integrated dual diagnosis care, and is proven to support long-term wellness and stronger recovery outcomes. A dual diagnosis, or diagnosis of...

Read more
BetterWay Launches GLP-1 Blood Testing Panel at Retail Locations in Austin and Temple
Healthcare & PharmaceuticalPartnerships

BetterWay Launches GLP-1 Blood Testing Panel at Retail Locations in Austin and Temple

January 29, 2026 10:50 AM

BetterWay™ blood testing by Babson Diagnostics, a science-first healthcare technology company transforming diagnostic blood testing, announced today that it will launch a GLP-1 test panel at over 25 Austin and Temple BetterWay collection locations including Sam's Club and Peoples Rx pharmacies-pairing GLP-1 prescriptions, including Wegovy's new oral GLP-1 option, with BetterWay's patient-preferred fingertip blood collection. The FDA's recent...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers • June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?